Vascular alterations among young adults with SARS-CoV-2

SM Ratchford, JL Stickford… - American Journal …, 2021 - journals.physiology.org
While SARS-CoV-2 primarily affects the lungs, the virus may be inflicting detriments to the
cardiovascular system, both directly through angiotensin-converting enzyme 2 receptor and …

The role of interleukin-8 in lung inflammation and injury: implications for the management of COVID-19 and hyperinflammatory acute respiratory distress syndrome

MC Cesta, M Zippoli, C Marsiglia, EM Gavioli… - Frontiers in …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus—2 (SARS CoV-2) has resulted in the
global spread of Coronavirus Disease 2019 (COVID-19) and an increase in complications …

I mmunosenescence and inflammaging: risk factors of severe COVID-19 in older people

AJ Pietrobon, FME Teixeira, MN Sato - Frontiers in immunology, 2020 - frontiersin.org
Old individuals are more susceptible to various infections due to immunological changes
that occur during the aging process. These changes named collectively as …

Cascade of immune mechanism and consequences of inflammatory disorders

KB Megha, X Joseph, V Akhil, PV Mohanan - Phytomedicine, 2021 - Elsevier
Inflammatory responses arise as an outcome of tissues or organs exposure towards harmful
stimuli like injury, toxic chemicals or pathogenic microorganism. It is a complex cascade of …

Encephalopathy in patients with COVID‐19: a review

RK Garg, VK Paliwal, A Gupta - Journal of Medical Virology, 2021 - Wiley Online Library
Encephalopathy and encephalitis are major and devastating severe acute respiratory
syndrome coronavirus‐2 (SARS‐CoV‐2) virus‐associated central nervous system …

Plants metabolites: possibility of natural therapeutics against the COVID-19 pandemic

FR Bhuiyan, S Howlader, T Raihan, M Hasan - Frontiers in medicine, 2020 - frontiersin.org
COVID-19, a disease induced by SARS-CoV-2 (Severe Acute Respiratory Syndrome
Coronavirus-2), has been the cause of a worldwide pandemic. Though extensive research …

[HTML][HTML] Late complications of COVID-19; a systematic review of current evidence

SA SeyedAlinaghi, AM Afsahi… - Archives of academic …, 2021 - ncbi.nlm.nih.gov
Methods: This study was a systematic review of current evidence conducted in November
2020 to investigate probable late and long-term complications of COVID-19. We performed a …

Small molecules in the treatment of COVID-19

S Lei, X Chen, J Wu, X Duan, K Men - Signal transduction and targeted …, 2022 - nature.com
The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to
societies and economies. Until now, effective therapeutics against COVID-19 are in high …

SARS-CoV-2: characteristics and current advances in research

Y Yang, Z Xiao, K Ye, X He, B Sun, Z Qin, J Yu, J Yao… - Virology journal, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection has
spread rapidly across the world and become an international public health emergency. Both …

[HTML][HTML] Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis

JG Wilson, LJ Simpson, AM Ferreira, A Rustagi… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND Elevated levels of inflammatory cytokines have been associated with poor
outcomes among COVID-19 patients. It is unknown, however, how these levels compare …